The importance of circulating and disseminated tumor cells in pancreatic cancer

[1]  M. Makary,et al.  Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. , 2019, Annals of surgery.

[2]  C. Bassi,et al.  Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas. , 2019 .

[3]  Seung-Mo Hong,et al.  A "Clearer" View of Pancreatic Pathology: A Review of Tissue Clearing and Advanced Microscopy Techniques. , 2019, Advances in anatomic pathology.

[4]  M. Makary,et al.  Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study , 2018, Annals of surgery.

[5]  M. Makary,et al.  Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology. , 2018, The American journal of pathology.

[6]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[7]  C. Iacobuzio-Donahue,et al.  Unresolved endoplasmic reticulum stress engenders immune-resistant, latent pancreatic cancer metastases , 2017, Science.

[8]  J. Cameron,et al.  Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions , 2017, Pancreas.

[9]  J. Cameron,et al.  Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas , 2017, Annals of surgery.

[10]  J. Cameron,et al.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma , 2017, Annals of surgery.

[11]  Johannes G. Reiter,et al.  Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer , 2017, Nature Genetics.

[12]  Lynne Penberthy,et al.  Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013 , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[13]  J. Cameron,et al.  Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma , 2016, Annals of surgery.

[14]  J. Cameron,et al.  Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma , 2016, Clinical Cancer Research.

[15]  I. Astsaturov,et al.  Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma , 2016, Pancreas.

[16]  N. Aceto,et al.  Stem-like features of cancer cells on their way to metastasis , 2016, Biology Direct.

[17]  C. Iacobuzio-Donahue,et al.  Pancreatic cancer biology and genetics from an evolutionary perspective , 2016, Nature Reviews Cancer.

[18]  R. Hruban,et al.  Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms , 2016, Gut.

[19]  M R Speicher,et al.  The biology of circulating tumor cells , 2016, Oncogene.

[20]  M. Büchler,et al.  Main-duct Intraductal Papillary Mucinous Neoplasm: High Cancer Risk in Duct Diameter of 5 to 9 mm. , 2015, Annals of surgery.

[21]  K. Lillemoe,et al.  Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings. , 2015, Journal of the American College of Surgeons.

[22]  K. Lillemoe,et al.  Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer , 2015, Pancreas.

[23]  Donghong Zhang,et al.  Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer , 2015, International journal of cancer.

[24]  P. Bragado,et al.  Mechanisms of disseminated cancer cell dormancy: an awakening field , 2014, Nature Reviews Cancer.

[25]  Mahmood Ayub,et al.  Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer , 2014, Nature Medicine.

[26]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[27]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[28]  Qicheng Zhao,et al.  Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis , 2014, Tumor Biology.

[29]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[30]  F. Bidard,et al.  Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Tim Holland-Letz,et al.  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.

[32]  I. Vermes,et al.  Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer , 2012, Breast Cancer Research.

[33]  Seung‐Mo Hong,et al.  Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2′-Deoxycytidine , 2012, PloS one.

[34]  K. Pantel,et al.  Circulating epithelial cells in patients with benign colon diseases. , 2012, Clinical chemistry.

[35]  D. Greenwood,et al.  Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  H. Friess,et al.  The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. , 2012, Current molecular medicine.

[37]  Sepp Kaul,et al.  Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic Cancer Patients: A Feasibility Study , 2012, Oncology.

[38]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[39]  L Khoja,et al.  A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker , 2011, British Journal of Cancer.

[40]  A. Maitra,et al.  Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Michael Goggins,et al.  MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias , 2011, Clinical Cancer Research.

[42]  Pierre Michel,et al.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.

[43]  Mehmet Toner,et al.  Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer , 2010, Science Translational Medicine.

[44]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[45]  Patrik Rogalla,et al.  Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results , 2009, European Radiology.

[46]  S. Morrison,et al.  Efficient tumor formation by single human melanoma cells , 2008, Nature.

[47]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[48]  Jeffrey E. Lee,et al.  Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  Jeffrey E. Lee,et al.  Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  D. Simeone,et al.  Pancreatic cancer stem cells. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[52]  F. Itokawa,et al.  Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. , 2008, Journal of hepato-biliary-pancreatic surgery.

[53]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[54]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[55]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[56]  Thomas Kirchner,et al.  Migrating cancer stem cells — an integrated concept of malignant tumour progression , 2005, Nature Reviews Cancer.

[57]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[58]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[59]  Michio Shimizu,et al.  An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms , 2004, The American journal of surgical pathology.

[60]  J. Werner,et al.  Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. , 2001, Surgery.

[61]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[62]  R. Schulick,et al.  Main-duct Intraductal Papillary Mucinous Neoplasm. High Cancer Risk in Duct Diameter of 5 to 9 mm. , 2017, Annals of surgery.

[63]  Xuelei Ma,et al.  Prognostic role of circulating tumor cells in patients with pancreatic cancer: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[64]  P. Cirri,et al.  Cancer associated fibroblasts: the dark side of the coin. , 2011, American journal of cancer research.